Abstract
To describe the clinical characteristics and predictors of major outcomes in patients treated with tocilizumab (TCZ) for severe COVID-19 pneumonia. Case series of all sequential patients with severe COVID-19 pneumonia treated with TCZ at an Academic Spanish hospital (March 12 - May 2, 2020). Clinical outcomes: death, length of hospital stay. An early clinical response to TCZ (48-72 h after the administration) was assessed by variations in respiratory function markers, Brescia COVID Respiratory Severity Scale (BCRSS), inflammatory parameters, and patients' and physicians' opinion. Associations were tested by multiple logistic regression. From a cohort of 236 patients, 77 patients treated with TCZ were included (median age 62 years (IQR 53.0-72.0), 64.9% were males), 42.9% had Charlson index ≥3; hypertension (41.6%), obesity (34.7%), and diabetes (20.8%). Median follow-up was 83.0 days (78.0-86.5), no patient was readmitted. ICU admission was required for 42 (54.5%), invasive mechanical ventilation in 38 (49.4%) and 10 patients died (12.9% global, 23.8% at ICU admitted). After multivariate adjustment, TCZ response by BCRSS (OR 0.03 (0.01-0.68), p = 0.028), and Charlson index (OR 3.54 (1.20-10.44), p = 0.022) has been identified a...Continue Reading
Citations
Nov 17, 2020·Genome Génome / Conseil National De Recherches Canada·Wenxia LuoTed M Lakowski
Jan 6, 2021·Drug Research·Timotius Ivan HariyantoAndree Kurniawan
Jan 2, 2021·Frontiers in Pharmacology·Qi HanYuguo Chen
Oct 30, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Miguel Górgolas Hernández-MoraGermán Peces-Barba Romero
Jan 22, 2021·BMJ : British Medical Journal·Viviane C VeigaUNKNOWN Coalition covid-19 Brazil VI Investigators
Jan 7, 2021·Infection and Drug Resistance·Abdullahi Rabiu AbubakarMainul Haque
Oct 30, 2020·International Journal of Molecular Sciences·Jan BrábekKarel Smetana
Sep 21, 2020·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Oscar Moreno-PUNKNOWN COVID19-ALC Research Group
Feb 28, 2021·Medicina clínica·Violeta Esteban RondaEsperanza Merino de Lucas
Mar 23, 2021·Case Reports in Nephrology·José C De La FlorMiguel Rodeles
Mar 26, 2021·F1000Research·Cahyo Wibisono NugrohoJonny Karunia Fajar
Apr 2, 2021·Frontiers in Pharmacology·Zeinab AbdelrahmanXiaosheng Wang
Apr 11, 2021·Expert Review of Medical Devices·Maria Tsikala VafeaEleftherios Mylonakis
May 29, 2021·Experimental Gerontology·Kangqiao XuShijin Xia
Jul 7, 2021·Medicina Clínica·Violeta Esteban RondaEsperanza Merino de Lucas
Jul 7, 2021·International Journal of Clinical Practice·Jose-Manuel Ramos-RinconUNKNOWN COVID-19 ALC Research Group
Aug 27, 2021·Therapeutic Advances in Chronic Disease·Jin-Tao GuanZheng-Hao Xu
Sep 11, 2021·PloS One·Gianluca RussoMiriam Lichtner
Sep 25, 2021·Pharmacotherapy·Manuel Rubio-RivasXavier Corbella